Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02492672 · ClinicalTrials.gov registry record
Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease
A clinical trial, sponsored by American Regent.
- Completed
- Registry status
- 50
- Enrollment target
NCT02492672 is a clinical trial that has completed, run by American Regent. The registered enrollment target is 50 participants.
The verdict
NCT02492672 has completed, sponsored by American Regent.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The current registry is being undertaken to assess the long-term (12 month) safety and tolerability of Venofer in the pediatric population with chronic kidney disease that requires intravenous iron maintenance therapy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-09 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02492672
The ClinicalTrials.gov registry entry for NCT02492672 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is American Regent, which has 34 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02492672 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02492672 about?
NCT02492672 is a clinical study titled "Registry to Evaluate Maintenance Treatment With Venofer in Pediatric Patients With Chronic Kidney Disease". The current registry is being undertaken to assess the long-term (12 month) safety and tolerability of Venofer in the pediatric population with chronic kidney disease that requires intravenous iron maintenance therapy.
What is the current status of trial NCT02492672?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2014-09. Estimated completion is 2018-12.
Who is sponsoring clinical trial NCT02492672?
This trial is sponsored by American Regent, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.